Explore 3 Stock Ideas & Industry Insights Download Free Report

mid-cap

This Pharma Stock’s USD 14 Million Bet on Next-Generation Organ Transplantation

Aug 28, 2026 | Team Kalkine
This Pharma Stock’s USD 14 Million Bet on Next-Generation Organ Transplantation
Image source: shutterstock

  • NATCOPHARM:NSE
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (INR)

This report is an updated version of report published on 28 August 2026 as on 12:31 PM IST

Company overview: Natco Pharma Limited (NSE: NATCOPHARM) is an India-based pharmaceutical company focused on research, development, manufacturing, and marketing of generic medicines, specialty drugs, APIs, and agrochemical products. The company operates across pharmaceuticals and crop protection segments, serving domestic and international markets through vertically integrated operations and multiple manufacturing facilities in India. Kalkine’s Daily Report covers the Key Financial Metrics, Risks, Outlook, and Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

Section 1.0: Key Metrics in Pictures


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…